Literature DB >> 18000817

Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels.

Matthew Schrag1, Sunita Sharma, Holly Brown-Borg, Othman Ghribi.   

Abstract

The Ames dwarf mouse has a long lifespan and is characterized by a marked resistance to cellular stress, an event that is implicated in the pathogenesis of many neurodegenerative disorders that are associated with aging, including Alzheimer's disease. However, very little is known on the extent to which the Ames dwarf mouse is protected against Alzheimer's disease. We have developed an organotypic slice system cultured from hippocampi of adult dwarf mice and examined deleterious effects of beta-amyloid (Abeta) peptide, a key pathogenic event in the course of Alzheimer's disease. We present the first evidence that long living Ames mice resist beta-amyloid toxicity. We demonstrate that organotypic slices from adult dwarf mice, but not their normal phenotype counterparts (wild type), are resistant to Abeta25-35-induced hyperphosphorylation of tau protein, reduction in levels of the antiapoptotic protein Bcl-2, increase in levels of the pro-apoptotic protein Bax, and activation of caspase 3. Moreover, incubation of organotypic sections with the GSK-3beta inhibitor SB216763 prevented tau phosphorylation but not alterations in levels of Bcl-2, Bax, and caspase-3. Because the hippocampus is a brain area that is severely affected in Alzheimer's disease, our study proposes that organotypic slices from hippocampi of adult Ames dwarf mice may constitute a model system for understanding endogenous factors that may confer protection against Abeta. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18000817     DOI: 10.1002/hipo.20387

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  20 in total

1.  Protection of PMS777, a new AChE inhibitor with PAF antagonism, against amyloid-beta-induced neuronal apoptosis and neuroinflammation.

Authors:  Juan Li; Jinjia Hu; Biyun Shao; Wei Zhou; Yongyao Cui; Changzhi Dong; Jean-Marc Miezan Ezoulin; Xu Zhu; Wenlong Ding; Françoise Heymans; Hongzhuan Chen
Journal:  Cell Mol Neurobiol       Date:  2009-02-05       Impact factor: 5.046

2.  Amyloid beta-derived diffusible ligands (ADDLs) induce abnormal expression of insulin receptors in rat hippocampal neurons.

Authors:  Xin Liu; Zongyan Teng; Can Cui; Ruitao Wang; Meiling Liu; Yina Zhang
Journal:  J Mol Neurosci       Date:  2014-01-10       Impact factor: 3.444

Review 3.  Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Exp Gerontol       Date:  2014-09-28       Impact factor: 4.032

Review 4.  Pleiotropic effects of growth hormone signaling in aging.

Authors:  Andrzej Bartke
Journal:  Trends Endocrinol Metab       Date:  2011-08-17       Impact factor: 12.015

5.  Spatial memory is enhanced in long-living Ames dwarf mice and maintained following kainic acid induced neurodegeneration.

Authors:  Sunita Sharma; James Haselton; Sharlene Rakoczy; Stephanie Branshaw; Holly M Brown-Borg
Journal:  Mech Ageing Dev       Date:  2010-06-16       Impact factor: 5.432

Review 6.  Growth hormone, insulin and aging: the benefits of endocrine defects.

Authors:  Andrzej Bartke
Journal:  Exp Gerontol       Date:  2010-09-17       Impact factor: 4.032

7.  The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

Authors:  Kendra L Puig; Joshua A Kulas; Whitney Franklin; Sharlene G Rakoczy; Giulio Taglialatela; Holly M Brown-Borg; Colin K Combs
Journal:  Neurobiol Aging       Date:  2016-01-06       Impact factor: 4.673

Review 8.  Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle.

Authors:  Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

Review 9.  Reduced growth hormone signaling and methionine restriction: interventions that improve metabolic health and extend life span.

Authors:  Holly M Brown-Borg
Journal:  Ann N Y Acad Sci       Date:  2015-12-08       Impact factor: 5.691

10.  Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model.

Authors:  Edoardo Parrella; Tom Maxim; Francesca Maialetti; Lu Zhang; Junxiang Wan; Min Wei; Pinchas Cohen; Luigi Fontana; Valter D Longo
Journal:  Aging Cell       Date:  2013-03-11       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.